Capitalizing on Opportunities in Cord Blood
Don't read this unless you want to profit from the global
cord blood banking market.
Industry Report, November 2013
Format: PDF; 240 pages
The cord blood banking industry is one of the fastest growing industries in the world. There were only 23 active cord blood banks as of 2005, and now there are 485 worldwide. Cord blood banks now exist within 98 different countries around the world. That is a 21-fold increase (2,100%) in the companies involved in the industry, in less than a ten year period. This rapid market growth represents both an opportunity to profit, as well as swarming competition.
This industry report reveals strategies for dominating the global cord blood banking industry, including tactics for global expansion, patterns in regional dominance, and methods for investing in the sector. A distinctive feature of this report is a global survey of expectant parents who reveal their deepest fears, core expectations, and critical factors influencing buying decisions. It is designed to guide the decision-making of cord blood banks worldwide, as well as to advise investors entering the market. It is a road-map for modeling cord blood banks that have achieved successful and rapid growth.
It differs from the "Complete 2013-14 U.S. Cord Blood Banking Industry Report" in that it is a strategic overview of how to profit from global growth in cord blood banking, rather than from the U.S. markets alone.
A Rapid Growth Industry
For the past ten years, the global cord blood banking market has been experiencing rapid growth, in part, because it an early-stage market. It was not until 1974 that it was first proposed that stem and progenitor cells were present in human cord blood and 1983 that umbilical cord blood was proposed as an alternative source of stem cells for transplant. In 1988, the first successful cord blood transplant occurred, but it was not until 1995 that the first private cord blood bank began operations.
Furthermore, it was not until 2008 that a Taiwanese company, HealthBanks Biotech Company, Ltd., became the first private cord blood bank to offer umbilical cord tissue storage. HealthBaby, a Hong Kong based company, subsequently launched the service in 2009, and another Hong Kong based company, Cryolife, also added the service in 2009. As such, Asia is recognized as the geographic region that pioneered umbilical cord tissue preservation as a private service, but it has since has rapidly spread around the world.
For instance, nine U.S. cord blood banks now offer cord tissue storage. The first U.S. company to offer cord tissue storage was the Cord Blood Registry, who launched it in July of 2010. This represents an average of one new U.S. cord blood bank adding cord tissue storage as a service every 3-4 months. Similar trends have been observed within Europe, and to a slightly lesser extent, within the Middle East.
Report Format and Key Findings
In this comprehensive industry report, you'll learn:
Part 1: Global Cord Blood Banking Industry - Market Overview & Outlook
The first section of the report “roots” where the cord blood banking industry has been, what has shaped it, and where it is going. Using both qualitative and quantitative assessment, it explores critical timeline events, current and future conditions treatable, advantages of cord blood transplant, probabilities of requiring stem cell transplant throughout the lifespan, and more. With this detailed knowledge, you can know the relative strength of your position within the marketplace.
Part 2: Expansion and Growth – Trailing 12-Month Analysis & Forward Projections
The second section explores where the global cord blood banking industry is now and what you should anticipate for the near-term future, based on recent trends and five-year projections. Critically, it explores strategies of fast-growth companies and compares their actions and attributes to slow-growth companies, providing a comprehensive road-map to industry dominance.
Furthermore, detailed assessment of cord blood industry trends are presented in this section, including:
- Rates of worldwide cord blood storage (units per year)
- Medical society opinions of cord blood banking
- Cord blood scientific publication rates
- U.S. and worldwide grant funding analysis
- Cord blood patent breakdown
- Assessment of cord blood vs. cord tissue clinical trial frequency
- And much more
Part 3: Comprehensive Parent Survey - Continuing to Grow by Listening to Expectant Parents
While the last section showed you what to expect if trends continue as they are and revealed the environment that you will find yourself in within the next five years, this final section is your guide to taking strategic action and controlling your competitive position. This section contains findings from a global survey that reveal how parents learn about cord blood banking, think about the process, and make key decisions. This survey is your insight into the minds of your prospective clients.
Key findings from the survey include how to:
- Strategically position your products
- Understand why expectant parents bank publicly, privately, or not at all
- Communicate successfully with parents
- Effectively educate parents
- Prioritize your advertising budget
- Sell your services more effectively
In summary, this section is your guide to growing, expanding, and profiting, by listening to the needs of your clients – expectant parents.
Precise Market Size Determinations
A unique component of the report is the recent and precise market size determinations for the global cord blood banking industry. Analyzing historical data since 2004 and applying statistical modeling forward through 2018, detailed market projections are provided. In addition, these market size determinations are further segmented into United States (U.S.), European Union (EU), and worldwide data sets, all projected through 2018.
In aggregate, these market size determinations allow for accurate predictions of future market growth. Because no other company has historical data available for every geographical market segment of the cord blood banking industry since 2004 (10 years of trailing historical data), no other report can quantify the size and projected growth rate of the cord blood banking industry with such precision. Claim this report to view:
- 10 years of historical market size data (2004 to present)
- Current market size determinations
- 5 years of forward market size projections (through 2018)
- Size of individual market segments (U.S., European Union, and Worldwide)
For investors and venture capitalists, access to this market size information is essential to making profitable decisions and evaluating potential opportunities.
Why Claim the Report?
As mentioned above, this industry report is a comprehensive road-map for operating a successful cord blood bank. It takes you from the where the industry has been, to where it is now, to where is is going in the next five years. In addition, it gives you insider knowledge of how expectant parents think, so you can get there fast.
It teaches you - management of a private cord blood bank - how to strategically position your services to increase market share and attract expectant parents to your company.
Rather than focusing on the “medical” and “technical” aspects of cord blood stem cells, the report focuses on the practical and strategic applications necessary to successfully run a private cord blood bank. While the medical angle is interesting, you already know that part of your business. It would tell you nothing about strategic actions to take to have more expectant parents purchasing services from you, instead of the competition.
Instead, this industry report is focused on your needs and includes content relevant to what you want to know - how to optimally price your services, criteria that make expectant parents likely to purchase private cord blood banking services, and how to grow in a competitive industry.
Like it or not, the cord blood banking industry is getting more and more competitive every day. By doing nothing, clients will likely be won over by better informed, or simply more aggressive, competitors.
The Many Benefits to You
BioInformant only produces stem cell industry data. Because stem cells are richly populated in cord blood, we have been tracking the cord blood industry since 2005, when it was an early stage market. Unlike BioInformant, other publishers of cord blood data are broad range publishers without expertise in any specific area – this limits their ability to produce exactly what you need.
We understand the nuances of your business, because we have been analyzing your industry since 2005.
7 Years of Extensive Research & Experience
When we started tracking the cord blood banking industry seven years ago there were only 23 active cord blood banks. There are now 485 worldwide. That is a 21-fold increase (2,100%) in the number of companies involved within this industry, over only an eight year period.
This rapid market growth represents both an opportunity to profit, as well as swarming competition. Within the United States, there are now 70 active public and private cord blood banks, spread across nearly every U.S. state. Worldwide, there has been rapid industry expansion as well, with cord blood banks now in existence within nearly every developed country.
Understanding the drastic increase in the quantity of your competition makes it clear why you would benefit from the trends, market intelligence, and industry data in this report.
Substantiated Future Projections
We track this cord blood banking industry meticulously, year-after-year producing more revealing and accurate data. With great interest, we have annually identified the most successful industry participants and done careful study of the commonalities that exist among this group. We treat these companies as “models” for successful cord blood banking operations.
With equally great interest, we have also annually identified the least successful cord blood companies and done careful study to identify the commonalities that exist among this group. We treat these companies as “warnings” for how not to operate a cord blood bank, unless the goal is to run it into the ground.
In this report, we present our detailed findings for your benefit – we give you the road-map for how to be a fast-growth cord blood bank, so you can avoid the fate of a flat-growth company.
Optimal Foundation For Future Projections
Our historical knowledge of the cord blood industry also means that we have seven years of trailing data on the industry, and are therefore, optimally positioned to provide you with forward projections for the industry.
While no one can predict the future with 100% certainty, our foundation of knowledge means that we have the greatest likelihood of accurately predicting future trends and growth within the cord blood banking industry.
Make More Money
We are the only producer of data specific for cord blood banks that actually teaches you how to effectively sell your services, strategically position your products, and make more money.
Serving The Industry Elite
In a cut-throat industry, you need to access the tools that you competition already has. Because BioInformant has been the leading supplier of cord blood industry data since 2005, we have already served most of the world’s leading private cord blood banks.
Existing clients of ours include: The Virgin Health Bank, Canadian Blood Services, Cryo-Save AG, Insception Cord Blood Bank, StemCyte Inc., The New York Blood Center, Xytex Corporation, Cells For Life, SmartBank, NHS Cord Blood Bank (NHBTS), Secuvita, Eurocord, Neostem, Cord Life Singapore, Thermogenesis, Biosafe SA, Cryo-Save, The Till Group, Precious Cells, the National Marrow Donor Program (NMDP), and many more.
Serving The Rest of The Industry Too
While our sole focus has been on producing high quality market intelligence targeted for head management of private cord blood banks, we were surprised to find that a range of other companies also require reputable, accurate, and substantiated data for the cord blood industry.
These companies either expect to launch cord blood banking services, are interested in investing in companies within the cord blood industry, or they are interested in selling services to cord blood facilities. To this end, we often serve biotech venture capitalists, strategic consultancy companies, and healthcare organizations.
You Need Access To The Tools Your Competition Already Has
Other companies in the cord blood industry have already claimed this report and are implementing actions based on it. Can you afford to let them have that edge in an industry that has grown 21-times more competitive over the past seven years?
Direct Insight Into The Minds of Your Clients
This is the only cord blood industry market report available that includes direct insight (survey results) into the minds of expectant parents – your clients. We have interviewed hundreds of expectant parents worldwide, in order to understand how they view cord blood banking services.
We have explored how they perceive the benefits and drawbacks, how they describe their fears and motivations, and how they describe the decision-making process. We have captured this invaluable insight for you in Section 3 of the report - "Comprehensive Parent Survey - Continuing to Grow by Listening to Expectant Parents (237 Respondents)".
What You Can Expect
1) Increase Your Customer Base – Have more parents electing to use your cord blood banking services when you strategically understand your industry.
2) Become a Strategic Leader – Leverage this valuable, detailed, and rare information to ensure that you are fully equipped with the necessary information to successfully lead your company and achieve desired results.
3) Increase Profits - Make more profit while putting forth less effort than before.
4) Industry Security – Be able to both survive and thrive in the cord blood banking industry, even as it becomes much more competitive. Can you survive if the quantity of your competition doubles again? It is likely to happen.
5) Crush Competition – Be able to take away market share from the competition as you gain a strategic “edge."
Full-Satisfaction 60-Day Money-Back Guarantee
All BioInformant products come with a 100% Money Back Guarantee. If the strategies and tools aren't helpful to you - we'll cheerfully refund your money, and you can keep the product. You can return it by emailing us, without any questions or having to talk to a customer representative.
It is that easy to act, risk-free.
Claim Now & Receive Your Free Bonus
Act now and you will also receive BioInformant's “Global Cord Blood Industry Database, 2013," absolutely free.
This is a comprehensive database of the world’s active cord blood banks (485 total). It sells for $1,195 if purchased separately. But, we are providing it to you at no charge, if you act today.
The database now comes as 2 separate files:
1) A fully sortable database of all of the cord blood facilities worldwide
2) A ready-to-use email mailing list for contacts at cord blood facilities worldwide. Just upload it to your email marketing software and use it with the click of a "Send" Button.
You will receive it as an Excel file, so that you can execute any actions that you desire, such as sorting the data by Country, Company Name, or Company Details to assess market participant characteristics.
Few people in the world have this level of direct insight into the market conditions of the cord blood banking industry. If you act today, you can claim this database to become one of the few “in the know." Total, the database contains nearly 7,000 cord blood industry contacts. (View details.)
Actionable Information, Knowledge, & Expertise
Take full advantage of this offer while you can. These prices and especially the exclusive bonus are subject to change.
Your competitors would prefer you didn’t buy this report. But when you do, you’ll be gaining invaluable insights to help you dominate your industry.
And remember, there is no risk to you because if the strategies and tools in this industry report aren't helpful to you - we'll cheerfully refund your money, and you can keep the product.
Additional Product Details:
View Executive Summary
Table of Contents
Free Product Sample 1
Free Product Sample 2
Once your order is placed, you will be sent a download link for an electronic (PDF) version of the document. If you are claiming a hard-copy version, it will be delivered by postal mail. For your convenience, multiple license formats are available. All major international currencies accepted.
1. Claim by Secure Online Checkout:
2. Claim by Purchase Form:
To pay by credit card, check, or bank transfer, please complete and submit this Purchase Form.
3. Place a Direct Order:
To place a direct order, request a quote, or claim by PO, please contact us by emailing Info@BioInformant.com or calling 703.859.7617.
(Phone) 703-859-7617 firstname.lastname@example.org (Fax) 614-352-2369
Copyright © 2013 BioInformant Worldwide, L.L.C. All rights reserved.